Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

JOURNAL ARTICLE published 1 April 2019 in Clinical Cancer Research

Research funded by Cancer Prevention & Research Institute of Texas (RP150535) | NCI NIH (P30 CA016672)

Authors: Funda Meric-Bernstam | Amber M. Johnson | Ecaterina E. Ileana Dumbrava | Kanwal Raghav | Kavitha Balaji | Michelle Bhatt | Rashmi K. Murthy | Jordi Rodon | Sarina A. Piha-Paul